Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. HealthEquity Inc. shares valued at $324,694 were sold by Wellborn Gayle Furgurson on Dec 14. At $62.00 per share, Wellborn Gayle Furgurson sold 5,237 shares. The insider’s holdings dropped to 12,023 shares worth approximately $0.71 million following the completion of this transaction.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Also, Ladd Delano sold 5,897 shares, netting a total of over 442,275 in proceeds. Following the sale of shares at $75.00 each, the insider now holds 37,471 shares.
Before that, Trittschuh Larry L had sold 11,526 shares from its account. In a trade valued at $806,820, the EVP CHIEF SECURITY OFFICER traded HealthEquity Inc. shares for $70.00 each. Upon closing the transaction, the insider’s holdings decreased to 11,526 shares, worth approximately $1.65 million.
As published in a research note from Goldman on October 21, 2022, HealthEquity Inc. [HQY] has been rated up from a Sell to a Neutral and the price target has been revised to $77 from $64. This represents a 23.38% premium over Thursday’s closing price. Analysts at KeyBanc Capital Markets started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of July 12, 2022, Goldman has initiated its “Sell” rating for HQY. Earlier on April 11, 2022, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for HQY stock.
Analyzing HQY Stock Performance
On Thursday, HealthEquity Inc. [NASDAQ: HQY] rose 5.81% to $59.00. The stock’s lowest price that day was $54.15, but it reached a high of $59.21 in the same session. During the last five days, there has been a drop of approximately -11.26%. Over the course of the year, HealthEquity Inc. shares have dropped approximately -4.28%. Shares of the company reached a 52-week high of $68.83 on 03/08/23 and a 52-week low of $52.27 on 03/13/23. A 50-day SMA is recorded $61.45, while a 200-day SMA reached $64.27. Nevertheless, trading volume fell to 1.14 million shares from 2.35 million shares the previous day.
Support And Resistance Levels for HealthEquity Inc. (HQY)
According to the 24-hour chart, there is a support level at 55.70, which, if violated, would cause prices to drop to 52.39. In the upper region, resistance lies at 60.76. The next price resistance is at 62.51. RSI (Relative Strength Index) is 43.60 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.46, which suggests the price will decrease in the coming days. Percent R is at 59.36%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is HealthEquity Inc. subject to short interest?
Stocks of HealthEquity Inc. saw a sharp rise in short interest on Jan 12, 2023 jumping by 0.16 million shares to 2.98 million. Data from Yahoo Finance shows that the short interest on Dec 14, 2022 was 2.82 million shares. A jump of 5.37% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.9 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.9.
Which companies own the most shares of HealthEquity Inc. (HQY)?
According to BlackRock Fund Advisors filings, the company currently owns 9,157,122 shares, which is about 10.82% of the total HQY shares outstanding. The investor’s shares have appreciated by 513,328 from its previous 13-F filing of 8643794.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $527,542,482. Wasatch Advisors, Inc. acquire a 0.10% interest valued at $373.55 million while Fidelity Management & Research Co purchased a 307,894 stake. A total of -347,008 shares of HealthEquity Inc. were bought by William Blair Investment Manageme during the quarter, and 25,929 were bought by SSgA Funds Management, Inc. In its current portfolio, Brown Advisory LLC holds 1,982,714 shares valued at $129.21 million.
In terms of HealthEquity Inc. share price expectations, FactSet research, analysts set an average price target of $82.23 in the next 12 months, up nearly 50.65% from the previous closing price of $55.76. Analysts anticipate HealthEquity Inc. stock to reach $94.00 by 2023, with the lowest price target being $72.00. In spite of this, 13 analysts ranked HealthEquity Inc. stock as a Buy at the end of 2023. On April 07, 2022, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $89.